vs
Side-by-side financial comparison of GERON CORP (GERN) and RE/MAX Holdings, Inc. (RMAX). Click either name above to swap in a different company.
RE/MAX Holdings, Inc. is the larger business by last-quarter revenue ($71.1M vs $47.2M, roughly 1.5× GERON CORP). RE/MAX Holdings, Inc. runs the higher net margin — 2.0% vs -39.0%, a 41.0% gap on every dollar of revenue. On growth, GERON CORP posted the faster year-over-year revenue change (67.1% vs -1.8%). Over the past eight quarters, GERON CORP's revenue compounded faster (1597.0% CAGR vs -4.7%).
Geron Corporation is a biotechnology company located in Foster City, California which specializes in developing and commercializing therapeutic products for cancer that inhibit telomerase.
RE/MAX is an international real estate franchise operating in over 100 countries and territories that, in 2015, had over 100,000 agents in 6,800 offices.
GERN vs RMAX — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $47.2M | $71.1M |
| Net Profit | $-18.4M | $1.4M |
| Gross Margin | — | — |
| Operating Margin | -29.4% | 13.1% |
| Net Margin | -39.0% | 2.0% |
| Revenue YoY | 67.1% | -1.8% |
| Net Profit YoY | 30.3% | -75.2% |
| EPS (diluted) | $-0.03 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $71.1M | ||
| Q3 25 | $47.2M | $73.2M | ||
| Q2 25 | $49.0M | $72.8M | ||
| Q1 25 | $39.6M | $74.5M | ||
| Q4 24 | — | $72.5M | ||
| Q3 24 | $28.3M | $78.5M | ||
| Q2 24 | $882.0K | $78.5M | ||
| Q1 24 | $304.0K | $78.3M |
| Q4 25 | — | $1.4M | ||
| Q3 25 | $-18.4M | $4.0M | ||
| Q2 25 | $-16.4M | $4.7M | ||
| Q1 25 | $-19.8M | $-2.0M | ||
| Q4 24 | — | $5.8M | ||
| Q3 24 | $-26.4M | $966.0K | ||
| Q2 24 | $-67.4M | $3.7M | ||
| Q1 24 | $-55.4M | $-3.4M |
| Q4 25 | — | 13.1% | ||
| Q3 25 | -29.4% | 25.0% | ||
| Q2 25 | -25.4% | 19.3% | ||
| Q1 25 | -42.2% | 7.2% | ||
| Q4 24 | — | 5.9% | ||
| Q3 24 | -99.8% | 19.4% | ||
| Q2 24 | -7860.9% | 20.6% | ||
| Q1 24 | -18465.1% | 5.8% |
| Q4 25 | — | 2.0% | ||
| Q3 25 | -39.0% | 5.4% | ||
| Q2 25 | -33.4% | 6.4% | ||
| Q1 25 | -50.1% | -2.6% | ||
| Q4 24 | — | 8.0% | ||
| Q3 24 | -93.5% | 1.2% | ||
| Q2 24 | -7639.8% | 4.7% | ||
| Q1 24 | -18220.4% | -4.3% |
| Q4 25 | — | — | ||
| Q3 25 | $-0.03 | — | ||
| Q2 25 | $-0.02 | — | ||
| Q1 25 | $-0.03 | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-0.04 | — | ||
| Q2 24 | $-0.10 | — | ||
| Q1 24 | $-0.09 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $78.1M | $118.7M |
| Total DebtLower is stronger | — | $432.2M |
| Stockholders' EquityBook value | $248.7M | $452.4M |
| Total Assets | $567.4M | $582.5M |
| Debt / EquityLower = less leverage | — | 0.96× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $118.7M | ||
| Q3 25 | $78.1M | $107.5M | ||
| Q2 25 | $77.7M | $94.3M | ||
| Q1 25 | $83.7M | $89.1M | ||
| Q4 24 | — | $96.6M | ||
| Q3 24 | $60.3M | $83.8M | ||
| Q2 24 | $116.9M | $66.1M | ||
| Q1 24 | $189.8M | $82.1M |
| Q4 25 | — | $432.2M | ||
| Q3 25 | — | $433.3M | ||
| Q2 25 | — | $434.4M | ||
| Q1 25 | — | $435.3M | ||
| Q4 24 | — | $436.2M | ||
| Q3 24 | — | $437.2M | ||
| Q2 24 | — | $438.1M | ||
| Q1 24 | — | $439.0M |
| Q4 25 | — | $452.4M | ||
| Q3 25 | $248.7M | $448.1M | ||
| Q2 25 | $259.5M | $442.4M | ||
| Q1 25 | $268.2M | $433.5M | ||
| Q4 24 | — | $429.5M | ||
| Q3 24 | $292.3M | $423.1M | ||
| Q2 24 | $306.7M | $418.4M | ||
| Q1 24 | $344.9M | $412.0M |
| Q4 25 | — | $582.5M | ||
| Q3 25 | $567.4M | $582.2M | ||
| Q2 25 | $555.2M | $574.8M | ||
| Q1 25 | $562.5M | $571.4M | ||
| Q4 24 | — | $581.6M | ||
| Q3 24 | $444.9M | $578.6M | ||
| Q2 24 | $449.4M | $571.4M | ||
| Q1 24 | $482.1M | $566.7M |
| Q4 25 | — | 0.96× | ||
| Q3 25 | — | 0.97× | ||
| Q2 25 | — | 0.98× | ||
| Q1 25 | — | 1.00× | ||
| Q4 24 | — | 1.02× | ||
| Q3 24 | — | 1.03× | ||
| Q2 24 | — | 1.05× | ||
| Q1 24 | — | 1.07× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-13.6M | $40.9M |
| Free Cash FlowOCF − Capex | — | $33.5M |
| FCF MarginFCF / Revenue | — | 47.1% |
| Capex IntensityCapex / Revenue | — | 10.4% |
| Cash ConversionOCF / Net Profit | — | 28.39× |
| TTM Free Cash FlowTrailing 4 quarters | — | $56.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $40.9M | ||
| Q3 25 | $-13.6M | $17.7M | ||
| Q2 25 | $-27.4M | $4.6M | ||
| Q1 25 | $-48.0M | $5.7M | ||
| Q4 24 | — | $59.7M | ||
| Q3 24 | $-58.9M | $17.6M | ||
| Q2 24 | $-53.5M | $15.9M | ||
| Q1 24 | $-62.3M | $9.4M |
| Q4 25 | — | $33.5M | ||
| Q3 25 | — | $16.4M | ||
| Q2 25 | — | $2.9M | ||
| Q1 25 | — | $4.0M | ||
| Q4 24 | — | $53.0M | ||
| Q3 24 | — | $16.3M | ||
| Q2 24 | $-53.7M | $14.0M | ||
| Q1 24 | $-62.9M | $6.8M |
| Q4 25 | — | 47.1% | ||
| Q3 25 | — | 22.4% | ||
| Q2 25 | — | 4.0% | ||
| Q1 25 | — | 5.3% | ||
| Q4 24 | — | 73.2% | ||
| Q3 24 | — | 20.8% | ||
| Q2 24 | -6086.6% | 17.8% | ||
| Q1 24 | -20680.3% | 8.6% |
| Q4 25 | — | 10.4% | ||
| Q3 25 | — | 1.8% | ||
| Q2 25 | — | 2.2% | ||
| Q1 25 | — | 2.3% | ||
| Q4 24 | — | 9.1% | ||
| Q3 24 | 0.0% | 1.7% | ||
| Q2 24 | 23.4% | 2.4% | ||
| Q1 24 | 202.3% | 3.3% |
| Q4 25 | — | 28.39× | ||
| Q3 25 | — | 4.45× | ||
| Q2 25 | — | 0.97× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 10.28× | ||
| Q3 24 | — | 18.22× | ||
| Q2 24 | — | 4.29× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GERN
Segment breakdown not available.
RMAX
| Franchising Segment | $50.1M | 70% |
| Broker Fees | $13.9M | 20% |
| Annual Dues | $7.4M | 10% |
